Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Shaoyu Yang, Doctor
CONTACT
Xiao Xu, Head of Administrator
CONTACT
Lead
Energenx Medical LTD.
Safety, technical feasibility including procedure operation success and tumor ablation technical success be evaluated. The primary efficacy endpoint is the complete ablation rate of the ablated lesions at month 6. Other efficacy endpoints are local tumor progression-Free Survival(PFS), Overall Survival (OS) and proportion of patients requiring initiation of other anti-tumor interventions through 12 months. Pulmonary function and quality of life (EORTC QLQ-C30, EORTC QLQ-LC13) will be assessed as well.
Age
18–79
Sex
ALL
Healthy volunteers
Not accepted